Platelet Activating Factor and Epidermal Cytotoxicity
Platelet Activating Factor and Epidermal Cytotoxicity
批准号:
7655038
负责人:
RAYMOND L KONGER
金额:
$38.5万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2014-03-31
关键词:
AcuteAgonistAntioxidantsApoptosisAreaBiological ModelsBurn injuryChronicClinicalColoradoCutaneousDNA DamageEicosanoidsEpidermal Growth Factor ReceptorFamilyFigs - dietaryFunctional disorderGenerationsHealth SciencesHumanIn VitroInflammationLaboratoriesLasersLeadLettersLipidsMalignant NeoplasmsMeasuresMediatingMediator of activation proteinMethodologyMorbidity - disease rateMusOxidative StressPPAR gammaPTGS2 genePharmaceutical PreparationsPharmacologyPlatelet Activating FactorProductionReactionReactive Oxygen SpeciesResearchResearch ProposalsRoleRunningScientistSkinSkin CancerStimulusStructureSurveysSystemTechniquesTestingUltraviolet B RadiationUltraviolet RaysUniversitiesVolatile Fatty Acidsbasebody systemcomputerized data processingcytokinecytotoxicitydesignin vivoin vivo Modelinhibitor/antagonistinsightirradiationkeratinocytelipid mediatormeetingsmortalitynoveloxidative damagepublic health relevanceresponsesublimationtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The signals and processes by which diverse stimuli lead to keratinocyte cytokine production and cytotoxicity are presently not well understood. Moreover, chronic stimulation by agents such as ultraviolet radiation leads to malignancy. Recent studies have demonstrated that ultraviolet B radiation (UVB) damages human keratinocytes (HK) in part by inducing oxidative stress and cytokine production. Severe UVB damage to the keratinocyte can also result in apoptosis, or programmed cell death. Previous studies by our group and others have indicated that keratinocyte damage, especially via agents that result in oxidative stress results in the production of glycerophosphocholines (GPC) that can act as agonists for the Platelet-activating Factor (PAF) or the peroxisome proliferator activated receptor gamma (PPAR3) systems. The long-term objective of this ongoing research application is to elucidate the role of these oxidized GPCs in the acute UVB-induced photoresponse. Three specific aims are designed to test the hypothesis that UVB-mediated oxidative damage to the keratinocyte results in the production of novel ox-GPCs that activate the PAF-R and PPAR3 systems. These novel lipids augment cytokine production, modulate apoptosis, and induce keratinocyte proliferation: 1). The effect of these ox-GPCs on acute UVB-mediated inflammation, cytokine production, DNA damage/apoptosis and proliferation will be assessed in mice deficient in PAF-R and epidermal PPAR3; 2) Mass spectrometric methodologies will be used to structurally characterize ox-GPCs produced in response to UVB; and 3) The role of these ox-GPCs in the acute UVB photoresponse in humans will be determined. We anticipate that these studies using novel in vitro and in vivo model systems and novel methodologies will result in the characterization of ox-GPCs with PAF-R- and PPAR3- agonistic effects in acute UVB-induced keratinocyte cytokine production, cytotoxicity, and proliferation. This information will aid in the understanding of the mechanism(s) by which oxidative stress can be involved in cutaneous pathophysiology. Since these mediators would be produced in response to oxidative stress in other organ systems, these studies should provide important insights into and tools to study the impact of ox-GPCs in human pathophysiology. PUBLIC HEALTH RELEVANCE: Ultraviolet B radiation (UVB) induces profound effects upon keratinocytes and is responsible for the majority of skin cancers. Recent studies by our group have demonstrated that UVB induces the production of glycerophosphocholines (GPC) that can act as agonists for the Platelet-activating Factor (PAF) or the peroxisome proliferator activated receptor gamma (PPAR3) systems. The proposed studies will determine the structures of, and define the role of these novel lipid mediators in the acute UVB photoresponse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Promotion of photocarcinogenesis by the senescent field and mechanisms for field persistence
-
批准号:10487791
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:RAYMOND L KONGER
-
依托单位:
Regulation of cutaneous immune function and anti-tumor immune responses by PPARgamma-mediated transrepressive signaling
-
批准号:9898276
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:RAYMOND L KONGER
-
依托单位:
Regulation of cutaneous immune function and anti-tumor immune responses by PPARgamma-mediated transrepressive signaling
-
批准号:10450626
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:RAYMOND L KONGER
-
依托单位:
Characterization of persistent hyperemic foci and their role in photocarcinogenes
-
批准号:8385329
-
项目类别:
-
资助金额:$24.47万
-
财政年份:2012
-
负责人:RAYMOND L KONGER
-
依托单位:
Characterization of persistent hyperemic foci and their role in photocarcinogenes
-
批准号:8529530
-
项目类别:
-
资助金额:$18.76万
-
财政年份:2012
-
负责人:RAYMOND L KONGER
-
依托单位:
Tumor Suppression Through Oxidized Glycerophosphocholines
-
批准号:8073411
-
项目类别:
-
资助金额:$1.14万
-
财政年份:2010
-
负责人:RAYMOND L KONGER
-
依托单位:
Tumor Suppression Through Oxidized Glycerophosphocholines
-
批准号:7894989
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2009
-
负责人:RAYMOND L KONGER
-
依托单位:
Tumor Suppression Through Oxidized Glycerophosphocholines
-
批准号:7708753
-
项目类别:
-
资助金额:$23.1万
-
财政年份:2009
-
负责人:RAYMOND L KONGER
-
依托单位:
Role of PPARgamma in ultraviolet stress responses
-
批准号:7460816
-
项目类别:
-
资助金额:$7.4万
-
财政年份:2007
-
负责人:RAYMOND L KONGER
-
依托单位:
Role of PPARgamma in ultraviolet stress responses
-
批准号:7304147
-
项目类别:
-
资助金额:$7.58万
-
财政年份:2007
-
负责人:RAYMOND L KONGER
-
依托单位:
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
-
批准号:6196488
-
项目类别:
-
资助金额:$12.35万
-
财政年份:2000
-
负责人:RAYMOND L KONGER
-
依托单位:
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
-
批准号:6657257
-
项目类别:
-
资助金额:$12.35万
-
财政年份:2000
-
负责人:RAYMOND L KONGER
-
依托单位:
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
-
批准号:6374347
-
项目类别:
-
资助金额:$12.35万
-
财政年份:2000
-
负责人:RAYMOND L KONGER
-
依托单位:
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
-
批准号:6532923
-
项目类别:
-
资助金额:$12.35万
-
财政年份:2000
-
负责人:RAYMOND L KONGER
-
依托单位:
ROLE OF PGE2 RECEPTORS EP2 AND EP3 ON SENESCENCE
-
批准号:6778154
-
项目类别:
-
资助金额:$12.35万
-
财政年份:2000
-
负责人:RAYMOND L KONGER
-
依托单位:
Platelet Activating Factor and Epidermal Cytotoxicity
-
批准号:8235011
-
项目类别:
-
资助金额:$38.12万
-
财政年份:1999
-
负责人:RAYMOND L KONGER
-
依托单位:
Platelet Activating Factor and Epidermal Cytotoxicity
-
批准号:8442893
-
项目类别:
-
资助金额:$36.29万
-
财政年份:1999
-
负责人:RAYMOND L KONGER
-
依托单位:
Platelet Activating Factor and Epidermal Cytotoxicity
-
批准号:8046442
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1999
-
负责人:RAYMOND L KONGER
-
依托单位:
Platelet Activating Factor and Epidermal Cytotoxicity
-
批准号:7810545
-
项目类别:
-
资助金额:$38.5万
-
财政年份:1999
-
负责人:RAYMOND L KONGER
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: